In The News Posted August 22, 2019 Share Posted August 22, 2019 DUBLIN, Aug. 22, 2019 /PRNewswire/ -- The "Investigation Report on China's Basiliximab Market, 2019-2023" report has been added to ResearchAndMarkets.com's offering. In China, 10.80% or about 150 million people have chronic kidney disease, and over 3 million of them have end-stage renal... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.